BeSound Opens NYC Flagship for Breast Cancer Screening

News related to:BeSound · 2 min read
NEW YORK, Oct. 15, 2026 /CourierPR/ -- BeSound, a women-founded company based in New York City, has opened its flagship location in the Flatiron district to revolutionize breast cancer screening with FDA-approved 3D automated breast ultrasound technology. The new facility, which aims to scale nationally, offers a pain-free, radiation-free alternative to traditional mammography, with results available within 24 to 48 hours.
The BeSound platform, which uses Invenia™ ABUS technology from GE HealthCare, is designed to detect cancers in dense breast tissue, where up to 40% of cancers can be missed by mammography. Unlike handheld ultrasound, which relies on the skill of the operator, every BeSound scan captures a standardized, full-volume 3D image of the entire breast. This consistency is crucial for the company's plans to integrate an AI layer that will help physicians read scans faster, spot subtle changes earlier, and track a woman's breast health over time.
BeSound's scans are available to women who can book online in minutes with no referral, and get same-day appointments. The company's approach is particularly beneficial for women with dense breast tissue, as these women are at higher risk of breast cancer and often face challenges with traditional mammography. By pairing GE HealthCare's hospital-grade technology with a model built around the patient experience, BeSound is bringing an exam once found mainly in select hospitals and breast centers to women where they live.
The technology has been clinically proven to detect 55% more invasive cancers than mammograms alone. Early detection remains one of the most powerful tools women have against breast cancer. When it is found at a localized stage, before it has spread beyond the breast, the five-year relative survival rate is over 99%. Those odds drop sharply once cancer reaches the lymph nodes or beyond, which is why a cancer hidden by dense tissue carries such a high cost.
By the end of 2026, BeSound anticipates offering insurance-covered scans through multiple payers in New York and additional expanding markets, alongside a mobile van to bring screening to more communities and through employer partnerships. The company's goal is to move breast care from reactive to proactive, helping women understand their personal risk, supply critical imaging for women with dense breasts, and catch cancer at the stage when it is most treatable.
In addition to its flagship location in Flatiron, BeSound is committed to expanding its services to reach more women. The company's plans include offering insurance-covered scans through multiple payers in New York and additional expanding markets, as well as a mobile van to bring screening to more communities and through employer partnerships.